High sugar and butter (HSB) diet induces obesity and metabolic syndrome with decrease in regulatory T cells in adipose tissue of mice

作者：Maioli Tatiani Uceli^*; Goncalves Juliana Lauar; Goncalves Miranda Mariana Camila; Martins Vinicius Dantas; Horta Laila Sampaio; Moreira Thais Garcias; Brunialti Godard Ana Lucia; Santiago Andrezza Fernanda; Caetano Faria Ana Maria

来源：Inflammation Research, 2016, 65(2): 169-178.

DOI：10.1007/s00011-015-0902-1

• Diet-induced obesity
• Dyslipidemia
• Glucose intolerance
• Regulatory T cells
• Adipokines
• Inflammation
• LAP(+) cells

The purpose of the study was to develop a novel diet based on standard AIN93G diet that would be able to induce experimental obesity and impair immune regulation with high concentrations of both carbohydrate and lipids.
To compare the effects of this high sugar and butter (HSB) diet with other modified diets, male C57BL/6 mice were fed either mouse chow, or AIN93G diet, or high sugar (HS) diet, or high-fat (HF) diet, or high sugar and butter (HSB) diet for 11 weeks ad libitum. HSB diet induced higher weight gain. Therefore, control AIN93G and HSB groups were chosen for additional analysis. Regulatory T cells were studied by flow cytometry, and cytokine levels were measured by ELISA.
Although HF and HSB diets were able to induce a higher weight gain compatible with obesity in treated mice, HSB-fed mice presented the higher levels of serum glucose after fasting and the lowest frequency of regulatory T cells in adipose tissue. In addition, mice that were fed HSB diet presented higher levels of cholesterol and triglycerides, hyperleptinemia, increased resistin and leptin levels as well as reduced adiponectin serum levels. Importantly, we found increased frequency of CD4(+)CD44(+) effector T cells, reduction of CD4(+)CD25(+)Foxp3(+) and Th3 regulatory T cells as well as decreased levels of IL-10 and TGF-beta in adipose tissue of HSB-fed mice.
Therefore, HSB represents a novel model of obesity-inducing diet that was efficient in triggering alterations compatible with metabolic syndrome as well as impairment in immune regulatory parameters.

• 出版日期2016-2